MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.70220

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025

Comparative Outcomes of Drug-Eluting Balloons Versus Drug-Eluting Stents in Patients With Diabetes Undergoing PPCI.

Shabeer Hassan, Sattar Saba, Arti F N U, Kumar Haimath, Iltaf Kashif, Zaryab Haider Muhammad, Haq Saqib Burhan Ul, Hassan Bari Muhammad, Karim Ali, Kumar Sameet, Shweta F N U, Payal F N U, Rumela F N U, Mastoi Mehak Gul, Parveen Abida

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The comparative outcomes of DEB vs. DES in diabetic patients undergoing PPCI are of significant clinical interest, as these patients often experience higher rates of restenosis and adverse outcomes.

AIMS: This study aimed to compare the outcomes of drug-eluting balloons (DEB) versus drug-eluting stents (DES) in diabetic patients undergoing primary percutaneous coronary intervention (PPCI).

METHODS

We conducted a retrospective analysis of 5668 diabetic patients who underwent PPCI, with 1734 patients in the DEB group and 3934 patients in the DES group. Baseline characteristics, angiographic features, and clinical outcomes, including procedural success, major adverse cardiovascular events (MACE), target lesion revascularization (TLR), restenosis, and bleeding complications, were compared between the two groups.

RESULTS

Both DEB and DES groups demonstrated high procedural success rates (97.6% and 98.4%, respectively), with no significant differences in MACE, death, myocardial infarction, or target vessel revascularization. Restenosis at 6 months occurred in 3.9% of the DEB group and 3.4% of the DES group (p = 0.21). Lesion length, diabetes duration, hypertension, and prior myocardial infarction were identified as significant predictors of adverse outcomes. Use of DES was associated with a higher risk of MACE, but this did not translate into significant differences in clinical outcomes.

CONCLUSION

Both DEB and DES are effective and safe treatment options for diabetic patients undergoing PPCI, with comparable outcomes in terms of procedural success, MACE, and restenosis.

Для цитирования: Shabeer Hassan, Sattar Saba, Arti F N U, Kumar Haimath, Iltaf Kashif, Zaryab Haider Muhammad, Haq Saqib Burhan Ul, Hassan Bari Muhammad, Karim Ali, Kumar Sameet, Shweta F N U, Payal F N U, Rumela F N U, Mastoi Mehak Gul, Parveen Abida. Comparative Outcomes of Drug-Eluting Balloons Versus Drug-Eluting Stents in Patients With Diabetes Undergoing PPCI.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2025. DOI: 10.1002/ccd.70220.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.